Decreased serum IL-18 levels during sublingual immunotherapy in children with allergic rhinitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039899

Enrollment

Unknown

Registered

2020-11-14

Start date

2018-10-01

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Group 2:0.9% normal salt solution

Group 1:SLIT

Eligibility

Sex/Gender

Male

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: Forty-two AR children younger than 18 years old were recruited from clinic from October 2018 and October 2019 in this study. All the children had positive skin prick test or specific immunoglobulin to Dermatophagodes pteronyssinus and/or Dermatophagodes farina as well as allergen related clinical symptoms.

Exclusion criteria

Exclusion criteria: Children with allergic to other allergens and asthma were excluded.

Design outcomes

Primary

Measure	Time frame
IL-18;	—

Countries

China

Contacts

Public ContactChuling Li

Dongguan Women and Children's Hospital

chulinglidg@163.com+86 13316095370

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026